Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: Results of two similarly designed studies

Steven S. Smugar*, Thomas J. Schnitzer, Arthur L. Weaver, Bernard R. Rubin, Adam B. Polis, Andrew M. Tershakovec

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: Results of two similarly designed studies'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

INIS